Sankesh Abbhi is Director at BRAINSTORM CELL THERAPEUTICS INC. (BCLI). They have made 1 open-market trade across 1 company since 2020, most recently 2021-12-10.
CIK 0001806887
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $608K since 2020, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| BCLI | 11,323 | $13K |
Shares reported on the most recent Form 4, priced at the 2021-12-10 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BCLI | BUY | 2020-07-15 | 2020-07-16 | $12.99 | $608K | +7.5% | +3.6% | +20.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.